Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMTI | Common Stock | Options Exercise | $17.9K | +7.5K | $2.38* | 7.5K | Jul 7, 2021 | Direct | ||
transaction | AMTI | Common Stock | Sale | -$279K | -6.65K | -88.68% | $42.01* | 849 | Jul 7, 2021 | Direct | F1, F2 |
transaction | AMTI | Common Stock | Sale | -$34.1K | -800 | -94.23% | $42.67* | 49 | Jul 7, 2021 | Direct | F1, F3 |
transaction | AMTI | Common Stock | Sale | -$2.15K | -49 | -100% | $43.84* | 0 | Jul 7, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMTI | Stock Option (Right to Buy) | Options Exercise | $0 | -7.5K | -5.24% | $0.00 | 136K | Jul 7, 2021 | Common Stock | 7.5K | $2.38 | Direct | F4 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on January 28, 2021. |
F2 | The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $42.51, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.58 to $42.73, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | 1/4th of the shares subject to the option became vested and exercisable on April 22, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, provided that reporting person is a service provider to the issuer as of each such vesting date. |